LAFVX | Affiliated Fund Class R6 | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Affiliated Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Affiliated Fund?

The Fund seeks to deliver long-term growth of capital and current income by investing primarily in dividend-paying stocks of large U.S. companies.

DIVIDEND PAYERS

True to its mandate, the Affiliated Fund is focused on companies that pay dividends.

VALUE FOCUSED

We believe a professionally-managed approach can identify companies with sustainable dividend policies whose stocks are attractively valued. 

GROWTH & INCOME

A portfolio of undervalued dividend-paying stocks may provide investors with long-term growth of capital and current income. 

Fund Basicsas of 10/31/2022

Total Net Assets
$5.56 B
Inception Date
06/30/2015
Dividend Frequency
Quarterly
Fund Expense Ratio
0.38%
Number of Holdings
60

Yield

12-Month Dividend Yield 1 as of 12/09/2022  

w/o sales charge 2.25%

30-Day Standardized Yield 2 as of 11/30/2022  

1.97%

Fund Expense Ratio :

0.38%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -6.30% -0.81% 6.52% 6.95% 10.73% -
Lipper Category Avg. Equity Income Funds -3.58% 2.38% 9.00% 8.13% 10.40% -
Russell 1000® Value Index -3.65% 2.42% 8.40% 7.86% 10.97% -

Fund Expense Ratio :

0.38%

Fund Expense Ratio :

0.38%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -18.97% -10.47% 2.85% 4.80% 9.04% -
Lipper Category Avg. Equity Income Funds -17.04% -9.44% 4.84% 5.77% 8.65% -
Russell 1000® Value Index -17.75% -11.36% 4.36% 5.29% 9.17% -

Fund Expense Ratio :

0.38%

RELATED CONTENT

Investing in Stocks: The Case for a Broader Global Focus
August 30, 2021

An allocation to non-U.S. equities could provide an effective complement to a U.S.-focused stock portfolio. Here’s why

TEN LARGEST HOLDINGS as of 10/31/2022View Portfolio

Holding Assets
JPMorgan Chase & Co 4.9%
UnitedHealth Group Inc 4.5%
NextEra Energy Inc 3.7%
Northrop Grumman Corp 3.3%
AbbVie Inc 3.1%
Ameriprise Financial Inc 3.0%
Chevron Corp 3.0%
Allstate Corp/The 2.8%
Morgan Stanley 2.6%
Raytheon Technologies Corp 2.6%
% of Total Assets 33.5%

INVESTMENT TEAM

Darnell Azeez
Darnell Azeez, CFA

Managing Director, Portfolio Manager

20 Years of Industry Experience

Marc O. Pavese
Marc O. Pavese, Ph.D.

Partner, Head of Data-Driven Insights

22 Years of Industry Experience

Ryan C. Howard
Ryan C. Howard, CFA

Portfolio Manager

19 Years of Industry Experience

Servesh Tiwari
Servesh Tiwari, CFA

Portfolio Manager

16 Years of Industry Experience

Supported By 35 Investment Professionals with 19 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

12-Month Dividend Yield 1 as of 12/09/2022  

w/o sales charge 2.25%

30-Day Standardized Yield 2 as of 11/30/2022  

  Subsidized3 Un-Subsidized4
w/o sales charge 1.97% 1.97%

Fund Expense Ratio :

0.38%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -6.30% -0.81% 6.52% 6.95% 10.73% -
Lipper Category Avg. Equity Income Funds -3.58% 2.38% 9.00% 8.13% 10.40% -
Russell 1000® Value Index -3.65% 2.42% 8.40% 7.86% 10.97% -

Fund Expense Ratio :

0.38%

Fund Expense Ratio :

0.38%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception
w/o sales charge -18.97% -10.47% 2.85% 4.80% 9.04% -
Lipper Category Avg. Equity Income Funds -17.04% -9.44% 4.84% 5.77% 8.65% -
Russell 1000® Value Index -17.75% -11.36% 4.36% 5.29% 9.17% -

Fund Expense Ratio :

0.38%

Year Fund Returns Russell 1000® Value Index
2021 27.14% 25.16%
2020 -0.95% 2.80%
2019 25.71% 26.54%
2018 -7.22% -8.27%
2017 16.47% 13.66%
2016 17.83% 17.34%
2015 -3.83% -3.83%
2014 12.34% 13.45%
2013 32.80% 32.53%
2012 16.36% 17.51%
2011 -7.47% -
2010 14.87% -
2009 19.94% -
2008 -36.87% -
2007 4.13% -
2006 18.17% -
2005 3.71% -
2004 13.15% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2022 -4.29% -11.82% -4.00% - -9.40%
2021 8.87% 5.66% 0.03% 10.50% 27.14%
2020 -27.88% 15.62% 5.44% 12.65% -0.95%
2019 10.68% 3.85% 2.56% 6.63% 25.71%
2018 -2.36% 0.57% 6.63% -11.38% -7.22%
2017 4.15% 2.12% 3.10% 6.22% 16.47%
2016 2.59% 3.28% 3.83% 7.10% 17.83%
2015 0.50% -1.14% -7.49% 4.62% -3.83%
2014 2.30% 4.13% -0.02% 5.49% 12.34%
2013 11.06% 3.95% 4.59% 9.98% 32.80%
2012 12.69% -4.57% 6.69% 1.41% 16.36%
2011 5.68% -2.57% -20.73% 13.37% -7.47%
2010 6.89% -14.30% 10.44% 13.55% 14.87%
2009 -16.35% 18.86% 16.46% 3.58% 19.94%
2008 -9.60% -5.95% -6.59% -20.51% -36.87%
2007 0.43% 5.27% 1.95% -3.39% 4.13%
2006 6.01% -0.36% 6.01% 5.52% 18.17%
2005 -2.53% -0.38% 4.32% 2.39% 3.71%
2004 - - - 11.04% 13.15%

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioningas of 09/30/2022

  • As of September 30, 2022, the Fund’s largest overweight position relative to its benchmark, the Russell 1000® Value Index, is in UnitedHealth Group Incorporated, a company that engages in the provision of health care coverage, software, and data consultancy services. We believe the company is attractively valued with a strong management team that has deployed cash wisely.
  • The Fund is overweight relative to its benchmark in NextEra Energy, an electric power and energy infrastructure company. We continue to view NextEra as a standout performer in the electric utility industry as they grow both their regulated and non-regulated businesses. We believe they are a top renewable energy play and will benefit as the demand for renewables continues to rise.
  • The Fund is also overweight relative to its benchmark in Northrop Grumman Corp., a defense contractor. We expect steady growth in U.S. defense spending based on escalating geopolitical tensions following Russia’s invasion of Ukraine but also related to long-term strategic competition between the U.S. and China. We expect Northrop Grumman to be the fastest growing U.S. defense contractor based on its large and ramping growth platforms that serve critical U.S. needs including B-21, Ground Based Strategic Deterrent (GBSD), and satellites.

PORTFOLIO DETAILS as of 10/31/2022

Total Net Assets
$5.56 B
Number of Holdings
60
Weighted Average Market Cap.
208.6 B
P/B Ratio
3.2x
P/E Ratio
14.8x

Contributors & Detractors as of  09/30/2022

Contributors

Holding Contribution
Cheniere Energy Inc 0.5%
Marathon Petroleum Corp. 0.4%
Ameriprise Financial Inc 0.2%
NASDAQ OMX Group, Inc. 0.1%
Lowe's Cos Inc 0.1%

Detractors

Holding Contribution
Organon & Co -0.6%
Pfizer, Inc. -0.6%
AbbVie, Inc. -0.4%
United Technologies Corp. -0.3%
Prologis Inc -0.3%

Attribution Analysis 

Affiliated Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 12/09/2022
$0.262
Dividend Frequency
Quarterly
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
09/28/2022 09/29/2022 09/29/2022 $0.08570 $15.12
06/28/2022 06/29/2022 06/29/2022 $0.09890 $15.68
03/29/2022 03/30/2022 03/30/2022 $0.07780 $18.15

Upcoming Dividend Payment Dates

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
12/27/2022 12/28/2022 12/28/2022

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/21/2022 11/22/2022 $0.9232 - $0.9232 $16.11

Upcoming Capital Gain Distribution

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Fees & Expenses

Fees & Expenses

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell 1000® Value Index measures the performance of those Russell 1000 companies with lower price-to-book ratios and lower forecasted growth values.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field